Physician Profile
Based in Columbus, OH, Matthew L. Mundwiler, MD is listed in the NPI registry under rheumatology. Matthew graduated from Toledo Medical College in 2003. Medicare claims data shows Matthew provided 102,388 services to 3,184 patients. The services billed most often include injection, tocilizumab, 1 mg, injection, golimumab, 1 mg, for intravenous use, and injection, infliximab, excludes biosimilar, 10 mg. NPI 1801928411 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
1211 DUBLIN RD
Columbus, OH 43215
170 Taylor Station Rd Ste 300
Columbus, OH 43213
Within Rheumatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Autoimmune
Bone
Bone Health
Connective Tissue
Genetic & Connective Tissue
Inflammatory
Joints
Nerve & Tendon
Skin & Soft Tissue
Skin & Vascular
Soft Tissue
Spine & Back
Vascular
Most searched procedures
Consultation
Consultations
Diagnostics & Injections
Education & Support
Imaging
Injections
Lab & Diagnostics
Lab Work
Medication Management
Pain Relief
Regenerative Medicine
102,388 services · 3,184 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
356 | More often than most peers in Rheumatology |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | Procedure | 20611 |
125 | More often than most peers in Rheumatology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
660 | More than most peers in Rheumatology |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96401 |
159 | As often as other peers in Rheumatology |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
151 | More often than most peers in Rheumatology |
| Administration of chemotherapy into vein, each additional hour | Treatment | 96415 |
142 | More often than most peers in Rheumatology |
| Injection, tocilizumab, 1 mg | Drug given | J3262 |
32,720 | As often as other peers in Rheumatology |
| Injection, golimumab, 1 mg, for intravenous use | Drug given | J1602 |
32,150 | More often than most peers in Rheumatology |
| Injection, infliximab, excludes biosimilar, 10 mg | Drug given | J1745 |
11,627 | More than most peers in Rheumatology |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0129 |
9,125 | As often as other peers in Rheumatology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Dr. Mundwiler is a rheumatologist in Columbus, OH. That is the designation recorded for this NPI in the federal registry, where it is listed as “Rheumatology”.
NPI registry
Dr. Mundwiler is listed at 1211 Dublin Rd, Columbus, OH 43215. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (614) 486-5200. Contact the office directly to confirm availability and scheduling.
NPI registry
Dr. Mundwiler's National Provider Identifier is 1801928411. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Dr. Mundwiler attended Toledo Medical College, graduating in 2003. This comes from the CMS National Downloadable File.
CMS public data
Dr. Mundwiler has 23 years experience. Calculated from a graduation year of 2003, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Dr. Mundwiler performs procedures including insertion of needle into vein for collection of blood sample and aspiration and/or injection of fluid large joint using ultrasound guidance; provides treatments such as administration of chemotherapy into vein, 1 hour or less and administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Mundwiler. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.